EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Outcomes from a Novel Approach to Studying Consumer Genetic Testing for Germline Cancer and Cardiovascular Risk

Madison K Kilbride iD, Daniel Chavez-Yenter, Bob Wong, J Scott Roberts iD, Jacqueline Park, Jason Iuliano, Angela R Bradbury

American Journal of Medical Genetics Part A · 2025

DOI: 10.1002/ajmg.a.64169 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Medical Genetics Part A, 2025. Verfasst von Madison K Kilbride und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Philosophy, University of Utah, Salt Lake City, Utah, USA. Hauptthemen laut MEDLINE: Genetic Testing, Cardiovascular Diseases, Neoplasms. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NHGRI NIH HHS, NIH HHS, National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Despite the growing availability of consumer genetic testing for serious disease risks, outcomes data remain limited for individuals undergoing testing for high‐ and moderate‐penetrance genes. To address this gap, we evaluated the feasibility of the Consumer Genetic Testing Outcomes Evaluation Paradigm (CGT‐OEP), a novel approach for studying cognitive, affective, and behavioral outcomes in individuals pursuing physician‐mediated genetic testing. We recruited participants to purchase Color Health's genetic test for cancer and cardiovascular disease risk. Participants completed Baseline (T0), Pre‐Disclosure (T1), and Two‐Week Post‐Disclosure (T2) surveys and shared results with the study team. Of 185 consented participants, 105 (56.8%) purchased tests, with 103 (98.1%) completing all requirements. Purchasers were predominantly white (89%), female (73%), and college‐educated (80%). Participants reported high satisfaction and minimal negative emotions, uncertainty, or decisional regret; most ( n = 67, 65%) planned to share results with providers. Although genetic knowledge increased and anxiety decreased post‐disclosure, many participants misinterpreted negative and VUS results as indicating lower‐than‐average risk for cancer ( n = 41, 42%) and cardiovascular disease ( n = 45, 46%). Our findings demonstrate that the CGT‐OEP is a feasible, effective approach for studying consumer genetic testing. While participants reported positive experiences, findings highlight concerns about result comprehension and potential false reassurance, particularly for negative/VUS results.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TestingCardiovascular DiseasesNeoplasmsHumansFemaleMaleMiddle AgedAdultGenetic Predisposition to DiseaseGerm-Line MutationAgedSurveys and Questionnaires

Stichwörter der Autor:innen

cancer geneticscardiovascular geneticsconsumer genetic testingpatient‐reported outcomesphysician‐mediated genetic testing

Autor:innen und Institutionen

  • Department of Philosophy, University of Utah, Salt Lake City, Utah, USA.
  • Department of Medical Ethics and Health Policy, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • Division of Hematology-Oncology, Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania, USA.
  • College of Nursing, University of Utah, Salt Lake City, Utah, USA.
  • Department of Health Behavior & Health Equity, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA.
  • College of Engineering, University of Utah, Salt Lake City, Utah, USA.

ORCID-Profile: Madison K Kilbride, J Scott Roberts

Förderung

  • NHGRI NIH HHS
  • NIH HHS
  • National Institutes of Health

Zitieren

APA

Kilbride, M. K., Chavez-Yenter, D., Wong, B., Roberts, J. S., Park, J., Iuliano, J., & Bradbury, A. R. (2025). Outcomes from a Novel Approach to Studying Consumer Genetic Testing for Germline Cancer and Cardiovascular Risk. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.64169

Vancouver

Kilbride MK, Chavez-Yenter D, Wong B, Roberts JS, Park J, Iuliano J, et al. Outcomes from a Novel Approach to Studying Consumer Genetic Testing for Germline Cancer and Cardiovascular Risk. American Journal of Medical Genetics Part A. 2025. doi:10.1002/ajmg.a.64169

BibTeX
@article{Kilbride2025,
  author = {Kilbride, Madison K and Chavez-Yenter, Daniel and Wong, Bob and Roberts, J Scott and Park, Jacqueline and Iuliano, Jason and Bradbury, Angela R},
  title = {Outcomes from a Novel Approach to Studying Consumer Genetic Testing for Germline Cancer and Cardiovascular Risk},
  journal = {American Journal of Medical Genetics Part A},
  year = {2025},
  doi = {10.1002/ajmg.a.64169}
}
Kostenlos starten →